JP2010166921A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010166921A5 JP2010166921A5 JP2010044336A JP2010044336A JP2010166921A5 JP 2010166921 A5 JP2010166921 A5 JP 2010166921A5 JP 2010044336 A JP2010044336 A JP 2010044336A JP 2010044336 A JP2010044336 A JP 2010044336A JP 2010166921 A5 JP2010166921 A5 JP 2010166921A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- amino acid
- acid sequence
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims 23
- 102000004196 processed proteins & peptides Human genes 0.000 claims 23
- 108090000765 processed proteins & peptides Proteins 0.000 claims 23
- 108091033319 polynucleotide Proteins 0.000 claims 18
- 239000002157 polynucleotide Substances 0.000 claims 18
- 102000040430 polynucleotide Human genes 0.000 claims 18
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 14
- 239000002773 nucleotide Substances 0.000 claims 12
- 125000003729 nucleotide group Chemical group 0.000 claims 12
- 125000003275 alpha amino acid group Chemical group 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 6
- 210000004027 cell Anatomy 0.000 claims 5
- 239000012634 fragment Substances 0.000 claims 5
- 230000000295 complement effect Effects 0.000 claims 3
- 239000013604 expression vector Substances 0.000 claims 3
- 230000028993 immune response Effects 0.000 claims 3
- 230000002163 immunogen Effects 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 229960005486 vaccine Drugs 0.000 claims 3
- 208000034762 Meningococcal Infections Diseases 0.000 claims 2
- 241000588650 Neisseria meningitidis Species 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 108091026890 Coding region Proteins 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 239000012472 biological sample Substances 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- 239000000523 sample Substances 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 210000001768 subcellular fraction Anatomy 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9810276.7A GB9810276D0 (en) | 1998-05-13 | 1998-05-13 | Novel compounds |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000548474A Division JP4707832B2 (ja) | 1998-05-13 | 1999-05-07 | 髄膜炎菌由来のｂａｓｂ０２９ポリヌクレオチドおよびポリペプチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010166921A JP2010166921A (ja) | 2010-08-05 |
| JP2010166921A5 true JP2010166921A5 (https=) | 2011-07-28 |
Family
ID=10831992
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000548474A Expired - Fee Related JP4707832B2 (ja) | 1998-05-13 | 1999-05-07 | 髄膜炎菌由来のｂａｓｂ０２９ポリヌクレオチドおよびポリペプチド |
| JP2010044336A Pending JP2010166921A (ja) | 1998-05-13 | 2010-03-01 | 髄膜炎菌由来のｂａｓｂ０２９ポリヌクレオチドおよびポリペプチド |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000548474A Expired - Fee Related JP4707832B2 (ja) | 1998-05-13 | 1999-05-07 | 髄膜炎菌由来のｂａｓｂ０２９ポリヌクレオチドおよびポリペプチド |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US6780419B1 (https=) |
| EP (2) | EP1621623A3 (https=) |
| JP (2) | JP4707832B2 (https=) |
| KR (4) | KR20080070073A (https=) |
| CN (1) | CN1322127C (https=) |
| AT (1) | ATE311457T1 (https=) |
| AU (1) | AU750032B2 (https=) |
| BR (1) | BR9910396A (https=) |
| CA (1) | CA2328403C (https=) |
| CY (1) | CY1105676T1 (https=) |
| CZ (1) | CZ299612B6 (https=) |
| DE (1) | DE69928658T2 (https=) |
| DK (1) | DK1078063T3 (https=) |
| ES (1) | ES2252946T3 (https=) |
| GB (1) | GB9810276D0 (https=) |
| HU (1) | HUP0102479A3 (https=) |
| IL (2) | IL139613A0 (https=) |
| NO (2) | NO326994B1 (https=) |
| NZ (1) | NZ508323A (https=) |
| PL (1) | PL197449B1 (https=) |
| TR (1) | TR200003347T2 (https=) |
| WO (1) | WO1999058683A2 (https=) |
| ZA (1) | ZA200006523B (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9726398D0 (en) * | 1997-12-12 | 1998-02-11 | Isis Innovation | Polypeptide and coding sequences |
| EP1047784B2 (en) † | 1998-01-14 | 2015-03-18 | Novartis Vaccines and Diagnostics S.r.l. | Neissera meningitidis antigens |
| GB9810276D0 (en) * | 1998-05-13 | 1998-07-15 | Smithkline Beecham Biolog | Novel compounds |
| CA2371994C (en) | 1999-02-26 | 2010-09-28 | Guido Grandi | Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs |
| GB9916529D0 (en) * | 1999-07-14 | 1999-09-15 | Chiron Spa | Antigenic peptides |
| JP2004508801A (ja) | 1999-10-29 | 2004-03-25 | カイロン ソチエタ ア レスポンサビリタ リミタータ | ナイセリア抗原性ペプチド |
| GB9928196D0 (en) | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
| PT2289545T (pt) * | 2000-01-17 | 2016-09-06 | Glaxosmithkline Biologicals Sa | Vacina de omv suplementada contra meningococos |
| NZ520445A (en) * | 2000-01-25 | 2004-02-27 | Univ Queensland | Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA |
| NZ521531A (en) | 2000-02-28 | 2005-12-23 | Chiron S | Heterologous expression of neisserial proteins |
| ATE469915T1 (de) | 2001-07-27 | 2010-06-15 | Novartis Vaccines & Diagnostic | Antikörper gegen das meningokokken adhäsin app |
| US20060057160A1 (en) | 2002-08-02 | 2006-03-16 | Ralph Biemans | Vaccine composition |
| HUE031886T2 (en) | 2002-10-11 | 2017-08-28 | Glaxosmithkline Biologicals Sa | Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines |
| NZ546430A (en) | 2003-10-02 | 2009-04-30 | Novartis Vaccines & Diagnostic | Liquid vaccines for multiple meningococcal serogroups |
| US7459930B2 (en) * | 2006-11-14 | 2008-12-02 | Micron Technology, Inc. | Digital calibration circuits, devices and systems including same, and methods of operation |
| GB0700562D0 (en) | 2007-01-11 | 2007-02-21 | Novartis Vaccines & Diagnostic | Modified Saccharides |
| GB0916570D0 (en) | 2009-09-21 | 2009-10-28 | Royal Holloway & Bedford New C | Method |
| WO2011110655A2 (en) | 2010-03-11 | 2011-09-15 | Glaxosmithkline Biologicals S.A. | Vaccine |
| ES2642184T3 (es) * | 2012-01-05 | 2017-11-15 | Deutsches Krebsforschungszentrum | Péptidos para su uso en el tratamiento y diagnóstico de cánceres positivos a IDH1 R132H |
| WO2018022031A1 (en) | 2016-07-27 | 2018-02-01 | Prysmian S.P.A. | Flexible optical-fiber ribbon |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4769240A (en) * | 1980-09-15 | 1988-09-06 | Bactex, Inc. | Pili of neisseria and vaccine compositions containing same |
| US4702911A (en) * | 1985-09-27 | 1987-10-27 | Immunomed Corporation | Preparation of bacterium pili subunits and vaccines containing pili subunits |
| RU2023448C1 (ru) | 1987-07-30 | 1994-11-30 | Сентро Насьональ Де Биопрепарадос | Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в |
| FR2682041B1 (fr) * | 1991-10-03 | 1994-01-14 | Pasteur Merieux Serums Vaccins | Vaccin contre les infections a neisseria meningitidis. |
| US6245337B1 (en) * | 1994-08-25 | 2001-06-12 | Washington University | Haemophilus adherence and penetration proteins |
| US6121037A (en) * | 1994-10-18 | 2000-09-19 | Stojiljkovic; Igor | Bacterial hemoglobin receptor genes |
| US5646259A (en) * | 1995-03-24 | 1997-07-08 | St. Louis University | DNA encoding haemophilus adhesion proteins |
| US6265567B1 (en) * | 1995-04-07 | 2001-07-24 | University Of North Carolina At Chapel Hill | Isolated FrpB nucleic acid molecule |
| CU22559A1 (es) * | 1996-01-17 | 1999-05-03 | Ct Ingenieria Genetica Biotech | Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión |
| GB9726398D0 (en) * | 1997-12-12 | 1998-02-11 | Isis Innovation | Polypeptide and coding sequences |
| EP1047784B2 (en) * | 1998-01-14 | 2015-03-18 | Novartis Vaccines and Diagnostics S.r.l. | Neissera meningitidis antigens |
| GB9810276D0 (en) * | 1998-05-13 | 1998-07-15 | Smithkline Beecham Biolog | Novel compounds |
| WO2000066741A2 (en) * | 1999-04-30 | 2000-11-09 | Chiron S.P.A. | Conserved neisserial antigens |
-
1998
- 1998-05-13 GB GBGB9810276.7A patent/GB9810276D0/en not_active Ceased
-
1999
- 1999-05-07 ES ES99924946T patent/ES2252946T3/es not_active Expired - Lifetime
- 1999-05-07 CN CNB998086061A patent/CN1322127C/zh not_active Expired - Fee Related
- 1999-05-07 AU AU41420/99A patent/AU750032B2/en not_active Ceased
- 1999-05-07 PL PL345281A patent/PL197449B1/pl not_active IP Right Cessation
- 1999-05-07 HU HU0102479A patent/HUP0102479A3/hu unknown
- 1999-05-07 KR KR1020087014761A patent/KR20080070073A/ko not_active Ceased
- 1999-05-07 WO PCT/EP1999/003255 patent/WO1999058683A2/en not_active Ceased
- 1999-05-07 CA CA2328403A patent/CA2328403C/en not_active Expired - Fee Related
- 1999-05-07 KR KR1020097024661A patent/KR20100019461A/ko not_active Ceased
- 1999-05-07 CZ CZ20004202A patent/CZ299612B6/cs not_active IP Right Cessation
- 1999-05-07 JP JP2000548474A patent/JP4707832B2/ja not_active Expired - Fee Related
- 1999-05-07 NZ NZ508323A patent/NZ508323A/xx not_active IP Right Cessation
- 1999-05-07 BR BR9910396-6A patent/BR9910396A/pt not_active Application Discontinuation
- 1999-05-07 EP EP20050077297 patent/EP1621623A3/en not_active Withdrawn
- 1999-05-07 KR KR1020007012700A patent/KR100673674B1/ko not_active Expired - Fee Related
- 1999-05-07 US US09/700,293 patent/US6780419B1/en not_active Expired - Lifetime
- 1999-05-07 TR TR2000/03347T patent/TR200003347T2/xx unknown
- 1999-05-07 EP EP99924946A patent/EP1078063B1/en not_active Expired - Lifetime
- 1999-05-07 IL IL13961399A patent/IL139613A0/xx unknown
- 1999-05-07 KR KR1020067009829A patent/KR100897951B1/ko not_active Expired - Fee Related
- 1999-05-07 DE DE69928658T patent/DE69928658T2/de not_active Expired - Lifetime
- 1999-05-07 DK DK99924946T patent/DK1078063T3/da active
- 1999-05-07 AT AT99924946T patent/ATE311457T1/de active
-
2000
- 2000-11-10 ZA ZA200006523A patent/ZA200006523B/xx unknown
- 2000-11-10 NO NO20005696A patent/NO326994B1/no not_active IP Right Cessation
- 2000-11-10 IL IL139613A patent/IL139613A/en not_active IP Right Cessation
-
2004
- 2004-07-22 US US10/896,778 patent/US20040265332A1/en not_active Abandoned
-
2006
- 2006-01-17 CY CY20061100057T patent/CY1105676T1/el unknown
-
2007
- 2007-12-07 US US11/999,978 patent/US20090093622A1/en not_active Abandoned
-
2009
- 2009-03-02 NO NO20090955A patent/NO20090955L/no not_active Application Discontinuation
-
2010
- 2010-03-01 JP JP2010044336A patent/JP2010166921A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010166921A5 (https=) | ||
| JP7744353B2 (ja) | プロピオニバクテリウム・アクネスの予防的かつ治療的な免疫処置 | |
| RU2012155702A (ru) | Композиция микробактериальных антигенов | |
| JP2010162023A5 (https=) | ||
| CN103007273B (zh) | 一种口蹄疫基因工程混合表位疫苗及其制备方法 | |
| CN102675471A (zh) | 猪口蹄疫病毒o型广谱多表位重组抗原及其应用 | |
| JP2002512800A5 (https=) | ||
| CN107432930B (zh) | 一种i群4型禽腺病毒dna疫苗及其制备方法和应用 | |
| CN113150084B (zh) | 一种纳米化的冠状病毒抗原及其应用 | |
| KR101919002B1 (ko) | 구제역 바이러스의 가용성 다가 항원단백질 및 이의 용도 | |
| CN116621971B (zh) | Hpv18亚型的纳米抗体及其应用 | |
| RU2016133598A (ru) | Композиция микобактериального антигена | |
| CN101289496A (zh) | 能激发机体抗结核杆菌的保护性免疫反应的抗原表位筛选方法及用途 | |
| CN106146626B (zh) | 一种红斑丹毒丝菌亚单位疫苗及制备方法及应用 | |
| WO2021042947A1 (zh) | 微环dna疫苗设计及应用 | |
| JP2014502143A5 (https=) | ||
| RU2012137304A (ru) | Рекомбинантные белки для применения в вакцине, антитела к указанным белкам и диагностические и терапевтические способы, включающие указанное | |
| CN103539839A (zh) | 肠道病毒71型的vp2抗原的中和表位多肽及其用途 | |
| CN108330142B (zh) | 一种具有免疫保护作用的美人鱼发光杆菌溶血素Hlych蛋白 | |
| CN102657864B (zh) | 一种口蹄疫疫苗的免疫佐剂及其应用 | |
| CN102905725B (zh) | 用于经典猪瘟的标记疫苗 | |
| Shen et al. | DNA vaccine prime and replicating vaccinia vaccine boost induce robust humoral and cellular immune responses against MERS-CoV in mice | |
| CN102847168B (zh) | 一种预防奶牛乳腺炎的核酸疫苗PV-Fn的设计及其构建 | |
| CN103352047A (zh) | 旋毛虫肌幼虫es抗原基因疫苗及其制备方法 | |
| CN106226520A (zh) | 结核分枝杆菌抗原蛋白Rv0865及其B细胞表位肽的应用 |